[The level of vasoactive prostanoids in patients with ischemic heart disease in the early period following aortocoronary bypass].
Bakhoviddinova
G Sh
GSh
D001241:Aspirin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000097:blood* / Q000188:drug therapy / Q000601:surgery; D004176:Dipyridamole / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D011464:Epoprostenol / Q000097:blood*; D006801:Humans; D010630:Phenindione / Q000008:administration & dosage; D011182:Postoperative Care; D011183:Postoperative Complications / Q000517:prevention & control; D013928:Thromboxane A2 / Q000097:blood*; D013997:Time Factors
D013928:Thromboxane A2; D010630:Phenindione; D004176:Dipyridamole; D011464:Epoprostenol; D001241:Aspirin
Soderzhanie vazoaktivnykh prostanoidov u bol'nykh ishemicheskoĭ bolezn'iu serdtsa v rannem periode posle aortokoronarnogo shuntirovaniia.